window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

obefazimod

  • Biologics & Biosimilars,Clinical studies,Clinical Trials,Pharmaceuticals and therapeutics

    Abivax shows anti-fibrotic activity for obefazimod in IBD at ECCO 2026

    Abivax has presented new preclinical and clinical data for obefazimod [...]

    February 23, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Almirall meets guidance with 12.4% net sales growth and dermatology portfolio progress in 2025
    Categories: Biologics & Biosimilars, Clinical studies, Dermatology, Pharmaceuticals and therapeutics
  • Abivax shows anti-fibrotic activity for obefazimod in IBD at ECCO 2026
    Categories: Biologics & Biosimilars, Clinical studies, Clinical Trials, Pharmaceuticals and therapeutics
  • Aspargo Labs appoints Sam Backenroth as chief financial officer to strengthen corporate and capital markets leadership
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Partnerships & Funding, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top